Ceramide Analysis in Combination With Genetic Testing May Provide a Precise Diagnosis for Self-Healing Collodion Babies

• Published in: Journal of lipid research Vol. 63; no. 12; p. 100308
• Main Authors: Takeichi, Takuya, Ohno, Yusuke, Tanahashi, Kana, Ito, Yasutoshi, Shiraishi, Ken, Utsunomiya, Ryo, Yoshida, Satoshi, Ikeda, Kenta, Nomura, Hayato, Morizane, Shin, Sayama, Koji, Ogi, Tomoo, Muro, Yoshinao, Kihara, Akio, Akiyama, Masashi
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.12.2022; Elsevier
• Subjects: acylceramide; autosomal recessive congenital ichthyosis; Ceramides - metabolism; Collodion; congenital ichthyosiform erythroderma; CYP4F22; epidermal ceramides; fatty acid ω-hydroxylase; Genetic Testing; Humans; Ichthyosis, Lamellar - diagnosis; Ichthyosis, Lamellar - genetics; Infant; Infant, Newborn; lipids; skin barrier; stratum corneum; tape stripping; skin barrier; lipids; WES; ARCI; fatty acid ω-hydroxylase; CYP4F22; ULC; autosomal recessive congenital ichthyosis; acylceramide; stratum corneum; tape stripping; SHCB; congenital ichthyosiform erythroderma; CLE; epidermal ceramides
• ISSN: 0022-2275; 1539-7262
• DOI: 10.1016/j.jlr.2022.100308

Self-healing collodion baby (SHCB), also called “self-improving collodion baby”, is a rare mild variant of autosomal recessive congenital ichthyosis and is defined as a collodion baby who shows the nearly complete resolution of scaling within the first 3 months to 1 year of life. However, during the neonatal period, it is not easy to distinguish SHCB from other inflammatory forms of autosomal recessive congenital ichthyosis, such as congenital ichthyosiform erythroderma. Here, we report a case study of two Japanese SHCB patients with compound heterozygous mutations, c.235G>T (p.(Glu79∗))/ c.1189C>T (p.(Arg397Cys)) and c.1295A>G (p.(Tyr432Cys))/ c.1138delG (p.(Asp380Thrfs∗3)), in CYP4F22, which encodes cytochrome P450, family 4, subfamily F, polypeptide 22 (CYP4F22). Immunohistochemically, inflammation with the strong expression of IL-17C, IL-36γ, and TNF-α was seen in the skin at birth. CYP4F22 is an ultra-long-chain FA ω-hydroxylase responsible for ω-O-acylceramide (acylceramide) production. Among the epidermal ceramides, acylceramide is a key lipid in maintaining the epidermal permeability barrier function. We found that the levels of ceramides with ω-hydroxy FAs including acylceramides and the levels of protein-bound ceramides were much lower in stratum corneum samples obtained by tape stripping from SHCB patients than in those from their unaffected parents and individuals without SHCB. Additionally, our cell-based enzyme assay revealed that two mutants, p.(Glu79∗) and p.(Arg397Cys), had no enzyme activity. Our findings suggest that genetic testing coupled with noninvasive ceramide analyses using tape-stripped stratum corneum samples might be useful for the early and precise diagnosis of congenital ichthyoses, including SHCB.